BSE · 524602
Bandaram Pharma Packtech Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹8 Cr with net profit ₹-0 Cr — a -4.02% net margin, versus -12.5% the period before.
Shareholding
As of 2026-06-30
- Promoter62.66%
- Public37.33%
- DII0%
5,103 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.49× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #43 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,472 Cr | 242.67 | 13.55 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,166 Cr | 315.74 | 10.07 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,876 Cr | 270.47 | 7.26 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,315 Cr | 187.89 | 9.34 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,227 Cr | 299.63 | 9.23 | 8.48% | 8.36% |
| Global Health Limited | ₹38,526 Cr | 267.33 | 9.72 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,517 Cr | 135.03 | 8.94 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,558 Cr | 239.5 | 12.58 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹17,015 Cr | 256.67 | 5.47 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,494 Cr | 391.04 | 7.65 | 6.58% | 6.4% |
| Bandaram Pharma Packtech Ltd.(this company) | ₹39 Cr | 86.36 | 1.42 | 1.67% | 0.52% |
AI analysis
AI-generated · google/gemini-2.5-flashBandaram Pharma Packtech Ltd. has a market capitalization of Rs 43 Cr. The company reported revenue of Rs 37.06 Cr and a profit margin of 52.4%. Earnings per share (EPS) for the last reported period was Rs 0.25, with a Return on Equity (ROE) of 167.3% and Return on Capital Employed (ROCE) of 3.8381%. The promoter holding stands at 62.6649%.
Positives
- +The company reported a high Return on Equity (ROE) of 167.3%.
- +Profit margin is 52.4%.
- +The promoter holding is 62.6649%, indicating significant insider ownership.
- +No promoter shares are reported as pledged.
Negatives
- −The debt-to-equity ratio is 1.18, indicating reliance on debt financing.
- −The company's P/E ratio is high at 96.76.
- −Quarterly results show negative net profit for June 2025 (-Rs 0.27 Cr), Sept 2025 (-Rs 0.35 Cr), and Dec 2025 (-Rs 0.21 Cr) in the annual data.
- −There are no dividend payouts, with a dividend yield of 0%.
Financial Performance
For the year ended Mar 2025, Bandaram Pharma Packtech Ltd. reported revenue of Rs 37.0576 Cr and a net profit of Rs 0.9938 Cr. The earnings per share (EPS) for this period was Rs 0.83. The company has not provided quarterly results since Mar 2026.
Profitability & Returns
The company's overall profit margin is 52.4%. Bandaram Pharma Packtech Ltd. achieved a Return on Equity (ROE) of 167.3% and a Return on Capital Employed (ROCE) of 3.8381%. The reported EPS is Rs 0.25.
Balance Sheet
Bandaram Pharma Packtech Ltd. has a debt-to-equity ratio of 1.18. The book value per share is Rs 14.9. The company's market capitalization stands at Rs 43 Cr.
Ownership & Pledges
Public shareholders account for 37.3318% of the ownership. There are no reported promoter share pledges.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Bandaram Pharma Packtech Ltd.share price & fundamentals